NDC 70518-2028

Breo Ellipta

Fluticasone Furoate And Vilanterol Trifenatate

Breo Ellipta is a Respiratory (inhalation) Powder in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Fluticasone Furoate; Vilanterol Trifenatate.

Product ID70518-2028_86bfbbaa-9de6-2805-e053-2991aa0a8c58
NDC70518-2028
Product TypeHuman Prescription Drug
Proprietary NameBreo Ellipta
Generic NameFluticasone Furoate And Vilanterol Trifenatate
Dosage FormPowder
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2019-04-17
Marketing CategoryNDA / NDA
Application NumberNDA204275
Labeler NameREMEDYREPACK INC.
Substance NameFLUTICASONE FUROATE; VILANTEROL TRIFENATATE
Active Ingredient Strength100 ug/1; ug/1
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-2028-0

1 TRAY in 1 CARTON (70518-2028-0) > 1 INHALER in 1 TRAY > 30 POWDER in 1 INHALER
Marketing Start Date2019-04-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-2028-0 [70518202800]

Breo Ellipta POWDER
Marketing CategoryNDA
Application NumberNDA204275
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-17

Drug Details

Active Ingredients

IngredientStrength
FLUTICASONE FUROATE100 ug/1

OpenFDA Data

SPL SET ID:37bfbe82-e68e-44d3-98f1-e9f71eb92fc9
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Adrenergic beta2-Agonists [MoA]
  • beta2-Adrenergic Agonist [EPC]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Adrenergic beta2-Agonists [MoA]
  • beta2-Adrenergic Agonist [EPC]

NDC Crossover Matching brand name "Breo Ellipta" or generic name "Fluticasone Furoate And Vilanterol Trifenatate"

NDCBrand NameGeneric Name
0173-0859Breo Elliptafluticasone furoate and vilanterol trifenatate
0173-0882Breo Elliptafluticasone furoate and vilanterol trifenatate
50090-2404Breo Elliptafluticasone furoate and vilanterol trifenatate
70518-2028Breo Elliptafluticasone furoate and vilanterol trifenatate

Trademark Results [Breo Ellipta]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BREO ELLIPTA
BREO ELLIPTA
85826011 4502969 Live/Registered
Glaxo Group Limited
2013-01-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.